Pharma & Healthcare
Global Pediatric Preventable Vaccine Market Research Report 2026
- Feb 03, 26
- ID: 695193
- Pages: 118
- Figures: 122
- Views: 3
This report delivers a comprehensive overview of the global Pediatric Preventable Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pediatric Preventable Vaccine. The Pediatric Preventable Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pediatric Preventable Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pediatric Preventable Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer Inc.
Merck & Co., Inc.
GlaxoSmithKline plc (GSK)
Sanofi Pasteur
Moderna, Inc.
Serum Institute of India Pvt.
Bharat Biotech International
CSL Limited (Seqirus)
Emergent BioSolutions Inc.
Daiichi Sankyo Company
Novavax, Inc.
Sinovac Biotech
Sinopharm Group Co.,
Johnson & Johnson (Janssen)
AstraZeneca plc
Segment by Type
Live Vaccines
Inactivated Vaccines
Subunit Vaccines
Mrna Vaccines
Viral Vector Vaccines
by Application
Bacterial Diseases
Virus Diseases
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pediatric Preventable Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pediatric Preventable Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Pediatric Preventable Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pediatric Preventable Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer Inc.
Merck & Co., Inc.
GlaxoSmithKline plc (GSK)
Sanofi Pasteur
Moderna, Inc.
Serum Institute of India Pvt.
Bharat Biotech International
CSL Limited (Seqirus)
Emergent BioSolutions Inc.
Daiichi Sankyo Company
Novavax, Inc.
Sinovac Biotech
Sinopharm Group Co.,
Johnson & Johnson (Janssen)
AstraZeneca plc
Segment by Type
Live Vaccines
Inactivated Vaccines
Subunit Vaccines
Mrna Vaccines
Viral Vector Vaccines
by Application
Bacterial Diseases
Virus Diseases
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pediatric Preventable Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pediatric Preventable Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Pediatric Preventable Vaccine Market Overview
1.1 Product Definition
1.2 Pediatric Preventable Vaccine by Type
1.2.1 Global Pediatric Preventable Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Live Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Subunit Vaccines
1.2.5 Mrna Vaccines
1.2.6 Viral Vector Vaccines
1.3 Pediatric Preventable Vaccine by Application
1.3.1 Global Pediatric Preventable Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Global Pediatric Preventable Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pediatric Preventable Vaccine Revenue 2021–2032
1.4.2 Global Pediatric Preventable Vaccine Sales 2021–2032
1.4.3 Global Pediatric Preventable Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pediatric Preventable Vaccine Market Competition by Manufacturers
2.1 Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pediatric Preventable Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pediatric Preventable Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pediatric Preventable Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pediatric Preventable Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Pediatric Preventable Vaccine, Date of Entry into the Industry
2.8 Global Pediatric Preventable Vaccine Market Competitive Situation and Trends
2.8.1 Global Pediatric Preventable Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pediatric Preventable Vaccine Players Market Share by Revenue
2.8.3 Global Pediatric Preventable Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Preventable Vaccine Market Scenario by Region
3.1 Global Pediatric Preventable Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pediatric Preventable Vaccine Sales by Region: 2021–2032
3.2.1 Global Pediatric Preventable Vaccine Sales by Region: 2021–2026
3.2.2 Global Pediatric Preventable Vaccine Sales by Region: 2027–2032
3.3 Global Pediatric Preventable Vaccine Revenue by Region: 2021–2032
3.3.1 Global Pediatric Preventable Vaccine Revenue by Region: 2021–2026
3.3.2 Global Pediatric Preventable Vaccine Revenue by Region: 2027–2032
3.4 North America Pediatric Preventable Vaccine Market Facts & Figures by Country
3.4.1 North America Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.4.3 North America Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Preventable Vaccine Market Facts & Figures by Country
3.5.1 Europe Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.5.3 Europe Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Preventable Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Preventable Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pediatric Preventable Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Pediatric Preventable Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Preventable Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Preventable Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Preventable Vaccine Sales by Type (2021–2032)
4.1.1 Global Pediatric Preventable Vaccine Sales by Type (2021–2026)
4.1.2 Global Pediatric Preventable Vaccine Sales by Type (2027–2032)
4.1.3 Global Pediatric Preventable Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Pediatric Preventable Vaccine Revenue by Type (2021–2032)
4.2.1 Global Pediatric Preventable Vaccine Revenue by Type (2021–2026)
4.2.2 Global Pediatric Preventable Vaccine Revenue by Type (2027–2032)
4.2.3 Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Pediatric Preventable Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pediatric Preventable Vaccine Sales by Application (2021–2032)
5.1.1 Global Pediatric Preventable Vaccine Sales by Application (2021–2026)
5.1.2 Global Pediatric Preventable Vaccine Sales by Application (2027–2032)
5.1.3 Global Pediatric Preventable Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Pediatric Preventable Vaccine Revenue by Application (2021–2032)
5.2.1 Global Pediatric Preventable Vaccine Revenue by Application (2021–2026)
5.2.2 Global Pediatric Preventable Vaccine Revenue by Application (2027–2032)
5.2.3 Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Pediatric Preventable Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Inc. Pediatric Preventable Vaccine Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Company Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck & Co., Inc. Pediatric Preventable Vaccine Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 GlaxoSmithKline plc (GSK)
6.3.1 GlaxoSmithKline plc (GSK) Company Information
6.3.2 GlaxoSmithKline plc (GSK) Description and Business Overview
6.3.3 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Portfolio
6.3.5 GlaxoSmithKline plc (GSK) Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Company Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sanofi Pasteur Pediatric Preventable Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Moderna, Inc.
6.5.1 Moderna, Inc. Company Information
6.5.2 Moderna, Inc. Description and Business Overview
6.5.3 Moderna, Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Moderna, Inc. Pediatric Preventable Vaccine Product Portfolio
6.5.5 Moderna, Inc. Recent Developments/Updates
6.6 Serum Institute of India Pvt.
6.6.1 Serum Institute of India Pvt. Company Information
6.6.2 Serum Institute of India Pvt. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Portfolio
6.6.5 Serum Institute of India Pvt. Recent Developments/Updates
6.7 Bharat Biotech International
6.7.1 Bharat Biotech International Company Information
6.7.2 Bharat Biotech International Description and Business Overview
6.7.3 Bharat Biotech International Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bharat Biotech International Pediatric Preventable Vaccine Product Portfolio
6.7.5 Bharat Biotech International Recent Developments/Updates
6.8 CSL Limited (Seqirus)
6.8.1 CSL Limited (Seqirus) Company Information
6.8.2 CSL Limited (Seqirus) Description and Business Overview
6.8.3 CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Portfolio
6.8.5 CSL Limited (Seqirus) Recent Developments/Updates
6.9 Emergent BioSolutions Inc.
6.9.1 Emergent BioSolutions Inc. Company Information
6.9.2 Emergent BioSolutions Inc. Description and Business Overview
6.9.3 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Portfolio
6.9.5 Emergent BioSolutions Inc. Recent Developments/Updates
6.10 Daiichi Sankyo Company
6.10.1 Daiichi Sankyo Company Company Information
6.10.2 Daiichi Sankyo Company Description and Business Overview
6.10.3 Daiichi Sankyo Company Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Daiichi Sankyo Company Pediatric Preventable Vaccine Product Portfolio
6.10.5 Daiichi Sankyo Company Recent Developments/Updates
6.11 Novavax, Inc.
6.11.1 Novavax, Inc. Company Information
6.11.2 Novavax, Inc. Description and Business Overview
6.11.3 Novavax, Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Novavax, Inc. Pediatric Preventable Vaccine Product Portfolio
6.11.5 Novavax, Inc. Recent Developments/Updates
6.12 Sinovac Biotech
6.12.1 Sinovac Biotech Company Information
6.12.2 Sinovac Biotech Description and Business Overview
6.12.3 Sinovac Biotech Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinovac Biotech Pediatric Preventable Vaccine Product Portfolio
6.12.5 Sinovac Biotech Recent Developments/Updates
6.13 Sinopharm Group Co.,
6.13.1 Sinopharm Group Co., Company Information
6.13.2 Sinopharm Group Co., Description and Business Overview
6.13.3 Sinopharm Group Co., Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sinopharm Group Co., Pediatric Preventable Vaccine Product Portfolio
6.13.5 Sinopharm Group Co., Recent Developments/Updates
6.14 Johnson & Johnson (Janssen)
6.14.1 Johnson & Johnson (Janssen) Company Information
6.14.2 Johnson & Johnson (Janssen) Description and Business Overview
6.14.3 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product Portfolio
6.14.5 Johnson & Johnson (Janssen) Recent Developments/Updates
6.15 AstraZeneca plc
6.15.1 AstraZeneca plc Company Information
6.15.2 AstraZeneca plc Description and Business Overview
6.15.3 AstraZeneca plc Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 AstraZeneca plc Pediatric Preventable Vaccine Product Portfolio
6.15.5 AstraZeneca plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Preventable Vaccine Industry Chain Analysis
7.2 Pediatric Preventable Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Preventable Vaccine Production Mode & Process Analysis
7.4 Pediatric Preventable Vaccine Sales and Marketing
7.4.1 Pediatric Preventable Vaccine Sales Channels
7.4.2 Pediatric Preventable Vaccine Distributors
7.5 Pediatric Preventable Vaccine Customer Analysis
8 Pediatric Preventable Vaccine Market Dynamics
8.1 Pediatric Preventable Vaccine Industry Trends
8.2 Pediatric Preventable Vaccine Market Drivers
8.3 Pediatric Preventable Vaccine Market Challenges
8.4 Pediatric Preventable Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pediatric Preventable Vaccine by Type
1.2.1 Global Pediatric Preventable Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Live Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Subunit Vaccines
1.2.5 Mrna Vaccines
1.2.6 Viral Vector Vaccines
1.3 Pediatric Preventable Vaccine by Application
1.3.1 Global Pediatric Preventable Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Global Pediatric Preventable Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pediatric Preventable Vaccine Revenue 2021–2032
1.4.2 Global Pediatric Preventable Vaccine Sales 2021–2032
1.4.3 Global Pediatric Preventable Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pediatric Preventable Vaccine Market Competition by Manufacturers
2.1 Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pediatric Preventable Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pediatric Preventable Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pediatric Preventable Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pediatric Preventable Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Pediatric Preventable Vaccine, Date of Entry into the Industry
2.8 Global Pediatric Preventable Vaccine Market Competitive Situation and Trends
2.8.1 Global Pediatric Preventable Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pediatric Preventable Vaccine Players Market Share by Revenue
2.8.3 Global Pediatric Preventable Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Preventable Vaccine Market Scenario by Region
3.1 Global Pediatric Preventable Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pediatric Preventable Vaccine Sales by Region: 2021–2032
3.2.1 Global Pediatric Preventable Vaccine Sales by Region: 2021–2026
3.2.2 Global Pediatric Preventable Vaccine Sales by Region: 2027–2032
3.3 Global Pediatric Preventable Vaccine Revenue by Region: 2021–2032
3.3.1 Global Pediatric Preventable Vaccine Revenue by Region: 2021–2026
3.3.2 Global Pediatric Preventable Vaccine Revenue by Region: 2027–2032
3.4 North America Pediatric Preventable Vaccine Market Facts & Figures by Country
3.4.1 North America Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.4.3 North America Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Preventable Vaccine Market Facts & Figures by Country
3.5.1 Europe Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.5.3 Europe Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Preventable Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Preventable Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pediatric Preventable Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Pediatric Preventable Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Preventable Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Preventable Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Preventable Vaccine Sales by Type (2021–2032)
4.1.1 Global Pediatric Preventable Vaccine Sales by Type (2021–2026)
4.1.2 Global Pediatric Preventable Vaccine Sales by Type (2027–2032)
4.1.3 Global Pediatric Preventable Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Pediatric Preventable Vaccine Revenue by Type (2021–2032)
4.2.1 Global Pediatric Preventable Vaccine Revenue by Type (2021–2026)
4.2.2 Global Pediatric Preventable Vaccine Revenue by Type (2027–2032)
4.2.3 Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Pediatric Preventable Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pediatric Preventable Vaccine Sales by Application (2021–2032)
5.1.1 Global Pediatric Preventable Vaccine Sales by Application (2021–2026)
5.1.2 Global Pediatric Preventable Vaccine Sales by Application (2027–2032)
5.1.3 Global Pediatric Preventable Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Pediatric Preventable Vaccine Revenue by Application (2021–2032)
5.2.1 Global Pediatric Preventable Vaccine Revenue by Application (2021–2026)
5.2.2 Global Pediatric Preventable Vaccine Revenue by Application (2027–2032)
5.2.3 Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Pediatric Preventable Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Inc. Pediatric Preventable Vaccine Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Company Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck & Co., Inc. Pediatric Preventable Vaccine Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 GlaxoSmithKline plc (GSK)
6.3.1 GlaxoSmithKline plc (GSK) Company Information
6.3.2 GlaxoSmithKline plc (GSK) Description and Business Overview
6.3.3 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Portfolio
6.3.5 GlaxoSmithKline plc (GSK) Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Company Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sanofi Pasteur Pediatric Preventable Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Moderna, Inc.
6.5.1 Moderna, Inc. Company Information
6.5.2 Moderna, Inc. Description and Business Overview
6.5.3 Moderna, Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Moderna, Inc. Pediatric Preventable Vaccine Product Portfolio
6.5.5 Moderna, Inc. Recent Developments/Updates
6.6 Serum Institute of India Pvt.
6.6.1 Serum Institute of India Pvt. Company Information
6.6.2 Serum Institute of India Pvt. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Portfolio
6.6.5 Serum Institute of India Pvt. Recent Developments/Updates
6.7 Bharat Biotech International
6.7.1 Bharat Biotech International Company Information
6.7.2 Bharat Biotech International Description and Business Overview
6.7.3 Bharat Biotech International Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bharat Biotech International Pediatric Preventable Vaccine Product Portfolio
6.7.5 Bharat Biotech International Recent Developments/Updates
6.8 CSL Limited (Seqirus)
6.8.1 CSL Limited (Seqirus) Company Information
6.8.2 CSL Limited (Seqirus) Description and Business Overview
6.8.3 CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Portfolio
6.8.5 CSL Limited (Seqirus) Recent Developments/Updates
6.9 Emergent BioSolutions Inc.
6.9.1 Emergent BioSolutions Inc. Company Information
6.9.2 Emergent BioSolutions Inc. Description and Business Overview
6.9.3 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Portfolio
6.9.5 Emergent BioSolutions Inc. Recent Developments/Updates
6.10 Daiichi Sankyo Company
6.10.1 Daiichi Sankyo Company Company Information
6.10.2 Daiichi Sankyo Company Description and Business Overview
6.10.3 Daiichi Sankyo Company Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Daiichi Sankyo Company Pediatric Preventable Vaccine Product Portfolio
6.10.5 Daiichi Sankyo Company Recent Developments/Updates
6.11 Novavax, Inc.
6.11.1 Novavax, Inc. Company Information
6.11.2 Novavax, Inc. Description and Business Overview
6.11.3 Novavax, Inc. Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Novavax, Inc. Pediatric Preventable Vaccine Product Portfolio
6.11.5 Novavax, Inc. Recent Developments/Updates
6.12 Sinovac Biotech
6.12.1 Sinovac Biotech Company Information
6.12.2 Sinovac Biotech Description and Business Overview
6.12.3 Sinovac Biotech Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinovac Biotech Pediatric Preventable Vaccine Product Portfolio
6.12.5 Sinovac Biotech Recent Developments/Updates
6.13 Sinopharm Group Co.,
6.13.1 Sinopharm Group Co., Company Information
6.13.2 Sinopharm Group Co., Description and Business Overview
6.13.3 Sinopharm Group Co., Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sinopharm Group Co., Pediatric Preventable Vaccine Product Portfolio
6.13.5 Sinopharm Group Co., Recent Developments/Updates
6.14 Johnson & Johnson (Janssen)
6.14.1 Johnson & Johnson (Janssen) Company Information
6.14.2 Johnson & Johnson (Janssen) Description and Business Overview
6.14.3 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product Portfolio
6.14.5 Johnson & Johnson (Janssen) Recent Developments/Updates
6.15 AstraZeneca plc
6.15.1 AstraZeneca plc Company Information
6.15.2 AstraZeneca plc Description and Business Overview
6.15.3 AstraZeneca plc Pediatric Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 AstraZeneca plc Pediatric Preventable Vaccine Product Portfolio
6.15.5 AstraZeneca plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Preventable Vaccine Industry Chain Analysis
7.2 Pediatric Preventable Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Preventable Vaccine Production Mode & Process Analysis
7.4 Pediatric Preventable Vaccine Sales and Marketing
7.4.1 Pediatric Preventable Vaccine Sales Channels
7.4.2 Pediatric Preventable Vaccine Distributors
7.5 Pediatric Preventable Vaccine Customer Analysis
8 Pediatric Preventable Vaccine Market Dynamics
8.1 Pediatric Preventable Vaccine Industry Trends
8.2 Pediatric Preventable Vaccine Market Drivers
8.3 Pediatric Preventable Vaccine Market Challenges
8.4 Pediatric Preventable Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pediatric Preventable Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pediatric Preventable Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pediatric Preventable Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pediatric Preventable Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pediatric Preventable Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pediatric Preventable Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pediatric Preventable Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Pediatric Preventable Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Preventable Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pediatric Preventable Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pediatric Preventable Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Pediatric Preventable Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Pediatric Preventable Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Pediatric Preventable Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pediatric Preventable Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pediatric Preventable Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pediatric Preventable Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pediatric Preventable Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Pediatric Preventable Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Pediatric Preventable Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Pediatric Preventable Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pediatric Preventable Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Pediatric Preventable Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Pediatric Preventable Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Pediatric Preventable Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Inc. Pediatric Preventable Vaccine Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Merck & Co., Inc. Company Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck & Co., Inc. Pediatric Preventable Vaccine Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. GlaxoSmithKline plc (GSK) Company Information
Table 81. GlaxoSmithKline plc (GSK) Description and Business Overview
Table 82. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product
Table 84. GlaxoSmithKline plc (GSK) Recent Developments/Updates
Table 85. Sanofi Pasteur Company Information
Table 86. Sanofi Pasteur Description and Business Overview
Table 87. Sanofi Pasteur Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sanofi Pasteur Pediatric Preventable Vaccine Product
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Moderna, Inc. Company Information
Table 91. Moderna, Inc. Description and Business Overview
Table 92. Moderna, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Moderna, Inc. Pediatric Preventable Vaccine Product
Table 94. Moderna, Inc. Recent Developments/Updates
Table 95. Serum Institute of India Pvt. Company Information
Table 96. Serum Institute of India Pvt. Description and Business Overview
Table 97. Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Serum Institute of India Pvt. Pediatric Preventable Vaccine Product
Table 99. Serum Institute of India Pvt. Recent Developments/Updates
Table 100. Bharat Biotech International Company Information
Table 101. Bharat Biotech International Description and Business Overview
Table 102. Bharat Biotech International Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Bharat Biotech International Pediatric Preventable Vaccine Product
Table 104. Bharat Biotech International Recent Developments/Updates
Table 105. CSL Limited (Seqirus) Company Information
Table 106. CSL Limited (Seqirus) Description and Business Overview
Table 107. CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CSL Limited (Seqirus) Pediatric Preventable Vaccine Product
Table 109. CSL Limited (Seqirus) Recent Developments/Updates
Table 110. Emergent BioSolutions Inc. Company Information
Table 111. Emergent BioSolutions Inc. Description and Business Overview
Table 112. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product
Table 114. Emergent BioSolutions Inc. Recent Developments/Updates
Table 115. Daiichi Sankyo Company Company Information
Table 116. Daiichi Sankyo Company Description and Business Overview
Table 117. Daiichi Sankyo Company Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Daiichi Sankyo Company Pediatric Preventable Vaccine Product
Table 119. Daiichi Sankyo Company Recent Developments/Updates
Table 120. Novavax, Inc. Company Information
Table 121. Novavax, Inc. Description and Business Overview
Table 122. Novavax, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Novavax, Inc. Pediatric Preventable Vaccine Product
Table 124. Novavax, Inc. Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sinovac Biotech Pediatric Preventable Vaccine Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Sinopharm Group Co., Company Information
Table 131. Sinopharm Group Co., Description and Business Overview
Table 132. Sinopharm Group Co., Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Sinopharm Group Co., Pediatric Preventable Vaccine Product
Table 134. Sinopharm Group Co., Recent Developments/Updates
Table 135. Johnson & Johnson (Janssen) Company Information
Table 136. Johnson & Johnson (Janssen) Description and Business Overview
Table 137. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product
Table 139. Johnson & Johnson (Janssen) Recent Developments/Updates
Table 140. AstraZeneca plc Company Information
Table 141. AstraZeneca plc Description and Business Overview
Table 142. AstraZeneca plc Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. AstraZeneca plc Pediatric Preventable Vaccine Product
Table 144. AstraZeneca plc Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pediatric Preventable Vaccine Distributors List
Table 148. Pediatric Preventable Vaccine Customers List
Table 149. Pediatric Preventable Vaccine Market Trends
Table 150. Pediatric Preventable Vaccine Market Drivers
Table 151. Pediatric Preventable Vaccine Market Challenges
Table 152. Pediatric Preventable Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pediatric Preventable Vaccine
Figure 2. Global Pediatric Preventable Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pediatric Preventable Vaccine Market Share by Type: 2025 & 2032
Figure 4. Live Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Mrna Vaccines Product Picture
Figure 8. Viral Vector Vaccines Product Picture
Figure 9. Global Pediatric Preventable Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Pediatric Preventable Vaccine Market Share by Application: 2025 & 2032
Figure 11. Bacterial Diseases
Figure 12. Virus Diseases
Figure 13. Global Pediatric Preventable Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Pediatric Preventable Vaccine Market Size (US$ Million), 2021–2032
Figure 15. Global Pediatric Preventable Vaccine Sales (K Units), 2021–2032
Figure 16. Global Pediatric Preventable Vaccine Average Price (US$/Unit), 2021–2032
Figure 17. Pediatric Preventable Vaccine Report Years Considered
Figure 18. Pediatric Preventable Vaccine Sales Share by Manufacturers in 2025
Figure 19. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Pediatric Preventable Vaccine Players: Market Share by Revenue in Pediatric Preventable Vaccine in 2025
Figure 21. Pediatric Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 24. North America Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 25. United States Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 28. Europe Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 29. Germany Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Pediatric Preventable Vaccine Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Pediatric Preventable Vaccine Revenue Market Share by Region (2021–2032)
Figure 36. China Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 44. Latin America Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Pediatric Preventable Vaccine by Type (2021–2032)
Figure 55. Global Revenue Market Share of Pediatric Preventable Vaccine by Type (2021–2032)
Figure 56. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Pediatric Preventable Vaccine by Application (2021–2032)
Figure 58. Global Revenue Market Share of Pediatric Preventable Vaccine by Application (2021–2032)
Figure 59. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 60. Pediatric Preventable Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Pediatric Preventable Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pediatric Preventable Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pediatric Preventable Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pediatric Preventable Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pediatric Preventable Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pediatric Preventable Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pediatric Preventable Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Pediatric Preventable Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Preventable Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pediatric Preventable Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pediatric Preventable Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Pediatric Preventable Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Pediatric Preventable Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Pediatric Preventable Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pediatric Preventable Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pediatric Preventable Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pediatric Preventable Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pediatric Preventable Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pediatric Preventable Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Pediatric Preventable Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Pediatric Preventable Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Pediatric Preventable Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pediatric Preventable Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Pediatric Preventable Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Pediatric Preventable Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Pediatric Preventable Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Inc. Pediatric Preventable Vaccine Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Merck & Co., Inc. Company Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck & Co., Inc. Pediatric Preventable Vaccine Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. GlaxoSmithKline plc (GSK) Company Information
Table 81. GlaxoSmithKline plc (GSK) Description and Business Overview
Table 82. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product
Table 84. GlaxoSmithKline plc (GSK) Recent Developments/Updates
Table 85. Sanofi Pasteur Company Information
Table 86. Sanofi Pasteur Description and Business Overview
Table 87. Sanofi Pasteur Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sanofi Pasteur Pediatric Preventable Vaccine Product
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Moderna, Inc. Company Information
Table 91. Moderna, Inc. Description and Business Overview
Table 92. Moderna, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Moderna, Inc. Pediatric Preventable Vaccine Product
Table 94. Moderna, Inc. Recent Developments/Updates
Table 95. Serum Institute of India Pvt. Company Information
Table 96. Serum Institute of India Pvt. Description and Business Overview
Table 97. Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Serum Institute of India Pvt. Pediatric Preventable Vaccine Product
Table 99. Serum Institute of India Pvt. Recent Developments/Updates
Table 100. Bharat Biotech International Company Information
Table 101. Bharat Biotech International Description and Business Overview
Table 102. Bharat Biotech International Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Bharat Biotech International Pediatric Preventable Vaccine Product
Table 104. Bharat Biotech International Recent Developments/Updates
Table 105. CSL Limited (Seqirus) Company Information
Table 106. CSL Limited (Seqirus) Description and Business Overview
Table 107. CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CSL Limited (Seqirus) Pediatric Preventable Vaccine Product
Table 109. CSL Limited (Seqirus) Recent Developments/Updates
Table 110. Emergent BioSolutions Inc. Company Information
Table 111. Emergent BioSolutions Inc. Description and Business Overview
Table 112. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product
Table 114. Emergent BioSolutions Inc. Recent Developments/Updates
Table 115. Daiichi Sankyo Company Company Information
Table 116. Daiichi Sankyo Company Description and Business Overview
Table 117. Daiichi Sankyo Company Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Daiichi Sankyo Company Pediatric Preventable Vaccine Product
Table 119. Daiichi Sankyo Company Recent Developments/Updates
Table 120. Novavax, Inc. Company Information
Table 121. Novavax, Inc. Description and Business Overview
Table 122. Novavax, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Novavax, Inc. Pediatric Preventable Vaccine Product
Table 124. Novavax, Inc. Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sinovac Biotech Pediatric Preventable Vaccine Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Sinopharm Group Co., Company Information
Table 131. Sinopharm Group Co., Description and Business Overview
Table 132. Sinopharm Group Co., Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Sinopharm Group Co., Pediatric Preventable Vaccine Product
Table 134. Sinopharm Group Co., Recent Developments/Updates
Table 135. Johnson & Johnson (Janssen) Company Information
Table 136. Johnson & Johnson (Janssen) Description and Business Overview
Table 137. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product
Table 139. Johnson & Johnson (Janssen) Recent Developments/Updates
Table 140. AstraZeneca plc Company Information
Table 141. AstraZeneca plc Description and Business Overview
Table 142. AstraZeneca plc Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. AstraZeneca plc Pediatric Preventable Vaccine Product
Table 144. AstraZeneca plc Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pediatric Preventable Vaccine Distributors List
Table 148. Pediatric Preventable Vaccine Customers List
Table 149. Pediatric Preventable Vaccine Market Trends
Table 150. Pediatric Preventable Vaccine Market Drivers
Table 151. Pediatric Preventable Vaccine Market Challenges
Table 152. Pediatric Preventable Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pediatric Preventable Vaccine
Figure 2. Global Pediatric Preventable Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pediatric Preventable Vaccine Market Share by Type: 2025 & 2032
Figure 4. Live Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Mrna Vaccines Product Picture
Figure 8. Viral Vector Vaccines Product Picture
Figure 9. Global Pediatric Preventable Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Pediatric Preventable Vaccine Market Share by Application: 2025 & 2032
Figure 11. Bacterial Diseases
Figure 12. Virus Diseases
Figure 13. Global Pediatric Preventable Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Pediatric Preventable Vaccine Market Size (US$ Million), 2021–2032
Figure 15. Global Pediatric Preventable Vaccine Sales (K Units), 2021–2032
Figure 16. Global Pediatric Preventable Vaccine Average Price (US$/Unit), 2021–2032
Figure 17. Pediatric Preventable Vaccine Report Years Considered
Figure 18. Pediatric Preventable Vaccine Sales Share by Manufacturers in 2025
Figure 19. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Pediatric Preventable Vaccine Players: Market Share by Revenue in Pediatric Preventable Vaccine in 2025
Figure 21. Pediatric Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 24. North America Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 25. United States Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 28. Europe Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 29. Germany Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Pediatric Preventable Vaccine Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Pediatric Preventable Vaccine Revenue Market Share by Region (2021–2032)
Figure 36. China Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 44. Latin America Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Pediatric Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Pediatric Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Pediatric Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Pediatric Preventable Vaccine by Type (2021–2032)
Figure 55. Global Revenue Market Share of Pediatric Preventable Vaccine by Type (2021–2032)
Figure 56. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Pediatric Preventable Vaccine by Application (2021–2032)
Figure 58. Global Revenue Market Share of Pediatric Preventable Vaccine by Application (2021–2032)
Figure 59. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 60. Pediatric Preventable Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232